Modeling Obesity and Weight Loss in Mice Using Novel AAV Approaches
Obesity · 2026
DOI: 10.1002/oby.70081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2026. Verfasst von Hunter G Sellers und 12 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: Weight Loss, Dependovirus, Obesity. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Objective
This study utilized AAV gene delivery as an approach to induce and reverse hyperphagia in mice. We hypothesized that the delivery of orexigenic neuropeptides to the brain via AAV precipitates obesity and that the implementation of genetic switches to reverse transgene expression would elicit weight loss.
Methods
We utilized capsid‐modified AAV‐PHP.eB and AAV‐CAP.B10 to deliver AgRP, NPY, a leptin superantagonist, and ghrelin to the mouse brain. Cre‐LoxP, TETOFF, and cumate expression systems were used to alter transgene expression.
Results
Delivery of three out of four orexigenic neuropeptides to the brain precipitated severe obesity. Cre‐mediated excision of AgRP from the brain caused a return to baseline weight, confounded by tamoxifen‐associated weight loss. Doxycycline‐mediated suppression of AgRP in a TETOFF vector paused weight gain but did not elicit weight loss. Cumate induction of AgRP in the brain was unaffected by systemic administration, suggesting that cumate inadequately penetrates the blood–brain barrier.
Conclusions
Brain‐targeted delivery of orexigenic peptides induces obesity in mice. This allows for temporally controlled, convenient, and robust preclinical models of obesity. The implementation of genetic switches enabled suppression/removal of AgRP expression, but we unexpectedly observed that removal of hyperphagic stimuli does not elicit robust weight loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
- Department of Neuroscience and Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
- Department of Pharmacology, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
- Department of Neurosurgery, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
ORCID-Profile: Hunter G Sellers, Eric J Belin de Chantemele
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Sellers, H. G., Brown, Z. L., Khalil, N. S., Haigh, S. B., Shivers, M. A., Patel, T. V., Joshua, A. T., Weintraub, N. L., Barman, S. A., Belin de Chantemele, E. J., Kirov, S. A., Stepp, D. W., & Fulton, D. J. R. (2026). Modeling Obesity and Weight Loss in Mice Using Novel AAV Approaches. Obesity. https://doi.org/10.1002/oby.70081
Vancouver
Sellers HG, Brown ZL, Khalil NS, Haigh SB, Shivers MA, Patel TV, et al. Modeling Obesity and Weight Loss in Mice Using Novel AAV Approaches. Obesity. 2026. doi:10.1002/oby.70081
BibTeX
@article{Sellers2026,
author = {Sellers, Hunter G and Brown, Zachary L and Khalil, Noureen S and Haigh, Stephen B and Shivers, Mitchell A and Patel, Tej V and Joshua, Austin T and Weintraub, Neal L and Barman, Scott A and Belin de Chantemele, Eric J and Kirov, Sergei A and Stepp, David W and Fulton, David J R},
title = {Modeling Obesity and Weight Loss in Mice Using Novel AAV Approaches},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70081}
}
EUVIMED